PharmaLegacyDrug metabolism and Pharmacokinetics (DMPK) deals with the fate of a drug administered by various routes in the living organism (humans and laboratory animals). It involves improving understanding of DMPK properties of the drug in experimental animals and humans and predict exposure-effect relationship with respect to time. In the past, suboptimal characterization and understanding of DMPK properties of drugs led to a much higher attrition/failure rate of drugs in the clinic. PharmaLegacy can provide a complete complementary PK/ADME service. Our team of DMPK scientists are dedicated to both discovery and development. This coupled with state-of-the-art instrumentation and supported by an AAALAC accredited vivarium, assists our clients from lead candidate selection through development and ensures a high quality of DMPK studies with cost-efficiency and fast turnaround. DMPK deals with the effect of human body on the drug. PharmaLegacy offers the clients a broad spectrum of high quality services in the areas of in vitro ADME, in vivo pharmacokinetics and bioanalysis services, with cost-efficiency and fast turnaround. The test articles range from small molecules to large molecules, such as protein and antibody. The animal species involved are non-human primate, canine, mice, rat, rabbit, guinea pig and mini pig.is focused on dmpk assays define, DMPK the unique advantages, DMPK the measures, Excellent DMPK and other projects. even though in the rapid development of the project ,PharmaLegacy always stressed the balance between external opportunities and internal management, attaches great importance to the core competitiveness of enterprises to cultivate and shape. Our company take the value of customer service as the core competitiveness of enterprises, adhering to the honesty and integrity , the pursuit of excellence, respect individual for the corporate spirit, and strive to provide customers with integrity and reliable DMPK.